{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:00Z","timestamp":1772166540982,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypereosinophilic syndrome is a group of disorders characterized by organ dysfunction caused by hypereosinophilia, which frequently leads to thromboembolic complications with potentially fatal outcomes. Interleukin-5, a key cytokine that promotes the differentiation and activation of eosinophils, has been identified as a therapeutic target. Anti-interleukin-5 antibody therapy has demonstrated efficacy in reducing eosinophil counts and enabling steroid dose tapering in patients with hypereosinophilic syndrome. This report describes the case of a patient with severe thromboembolism associated with hypereosinophilic syndrome during the acute phase who was successfully treated with benralizumab, an anti-interleukin-5 receptor alpha antibody.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 22-year-old woman presented with a persistent cough and was diagnosed with eosinophilic pneumonia and portal vein thrombosis. Although eosinophilic pneumonia improved with corticosteroid therapy, thrombotic complications worsened despite additional anticoagulant treatment. The administration of benralizumab led to marked improvement in thrombosis, resulting in clinical recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case suggests that the early administration of anti-interleukin-5 receptor antibody therapy may be a valuable treatment option for refractory thrombosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-025-00967-2","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T10:28:30Z","timestamp":1747477710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Daiki","family":"Nagira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Funauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsunori","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Higashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shiroyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tetsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","volume":"50","author":"C Curtis","year":"2016","unstructured":"Curtis C, Ogbogu P. Hypereosinophilic syndrome. Clin Rev Allergy Immunol. 2016;50:240\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"key":"967_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19812","volume":"4","author":"O Leiva","year":"2021","unstructured":"Leiva O, Baker O, Jenkins A, Brunner AM, Al-Samkari H, Leaf RK, et al. Association of thrombosis with hypereosinophilic syndrome in patients with genetic alterations. JAMA Netw Open. 2021;4: e2119812.","journal-title":"JAMA Netw Open"},{"key":"967_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100928","volume":"17","author":"M Caminati","year":"2024","unstructured":"Caminati M, Carpagnano LF, Alberti C, Amaddeo F, Bixio R, Caldart F, et al. Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: an innovative multidisciplinary approach. World Allergy Organ J. 2024;17: 100928.","journal-title":"World Allergy Organ J"},{"key":"967_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004658","volume":"95","author":"SJ Gao","year":"2016","unstructured":"Gao SJ, Wei W, Chen JT, Tan YH, Yu CB, Litzow MR, et al. Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: a case report and literature review. Med (Baltim). 2016;95: e4658.","journal-title":"Med (Baltim)"},{"key":"967_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124:1319-25.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"967_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jaip.2017.08.001","volume":"5","author":"FL Kuang","year":"2017","unstructured":"Kuang FL, Klion AD. Biologic agents for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol Pract. 2017;5:1502\u20139.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1038\/s41598-021-85852-9","volume":"11","author":"V R\u00e9au","year":"2021","unstructured":"R\u00e9au V, Vall\u00e9e A, Terrier B, Plessier A, Abisror N, Ackermann F, et al. Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep. 2021;11:6388.","journal-title":"Sci Rep"},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.seminhematol.2012.01.002","volume":"49","author":"HU Simon","year":"2012","unstructured":"Simon HU, Klion A. Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol. 2012;49:160\u201370.","journal-title":"Semin Hematol"},{"key":"967_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","volume":"27","author":"PU Ogbogu","year":"2007","unstructured":"Ogbogu PU, Rosing DR, Horne MK III. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27:457\u201375.","journal-title":"Immunol Allergy Clin North Am"},{"key":"967_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bjh.12729","volume":"165","author":"S Todd","year":"2014","unstructured":"Todd S, Hemmaway C, Nagy Z. Catastrophic thrombosis in idiopathic hypereosinophilic syndrome. Br J Haematol. 2014;165:425.","journal-title":"Br J Haematol"},{"key":"967_CR11","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1001\/archderm.142.12.1606","volume":"142","author":"B Terrier","year":"2006","unstructured":"Terrier B, Piette AM, Kerob D, Cordoliani F, Tancr\u00e8de E, Hamidou L, et al. Superficial venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome: study of the first 3 cases. Arch Dermatol. 2006;142:1606\u201310.","journal-title":"Arch Dermatol"},{"key":"967_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1067\/mai.2001.116576","volume":"108","author":"TK Hart","year":"2001","unstructured":"Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol. 2001;108:250\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"967_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.27287","volume":"99","author":"W Shomali","year":"2024","unstructured":"Shomali W, Gotlib J. World Health Organization and International consensus classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024;99:946\u201368.","journal-title":"Am J Hematol"},{"key":"967_CR14","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10498","volume":"14","author":"A Broyde","year":"2023","unstructured":"Broyde A, Elkayam O. Idiopathic eosinophilic vasculitis: case presentation and literature review. Rambam Maimonides Med J. 2023;14: e0011.","journal-title":"Rambam Maimonides Med J"},{"key":"967_CR15","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","volume":"125","author":"R Kolbeck","year":"2010","unstructured":"Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, et al. MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol. 2010;125:1344-53.e2.","journal-title":"J Allergy Clin Immunol"},{"key":"967_CR16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","volume":"380","author":"FL Kuang","year":"2019","unstructured":"Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, et al. Benralizumab for PDGFRA-negative hypereosinophilic syndrome. N Engl J Med. 2019;380:1336\u201346.","journal-title":"N Engl J Med"},{"key":"967_CR17","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134:1859\u201372.","journal-title":"Blood"},{"key":"967_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41569-024-01071-5","volume":"22","author":"J Xu","year":"2025","unstructured":"Xu J, Guo J, Liu T, Yang C, Meng Z, Libby P, et al. Differential roles of eosinophils in cardiovascular disease. Nat Rev Cardiol. 2025;22:165\u201382.","journal-title":"Nat Rev Cardiol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-025-00967-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T10:28:31Z","timestamp":1747477711000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-025-00967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s13223-025-00967-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6043550\/v1","asserted-by":"object"}]},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Oral informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}